News

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...
The U.S. Food and Drug Administration (FDA) on April 10, 2025, announced a significant policy shift aimed at reducing its reliance on animal ...
Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.
The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...
In other news, the US Food and Drug Administration is now reducing animal testing for drug development and will replace it ...